Concepedia

Jeremy Hofer

JH

Statistics

Publications

5

Citations

88

H-Index

5

Active since

2018

Affiliations

Widener University(Current)

NanoBio (United States)

Jeremy Hofer is an author at Widener University specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2018–2022

5

Publications

5

Identification of the FDA‐Approved Drug Pyrvinium as a Small‐Molecule Inhibitor of the PD‐1/PD‐L1 Interaction

Elena Fattakhova, Jeremy Hofer, Juliette DiFlumeri et al. · ChemMedChem · 2021 · 24 citations

, , +16

Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1–PDL1 Protein–Protein Interaction

Sachin Patil, Suk-Chung Yoon, Abhay G. Aradhya et al. · Chemical and Pharmaceutical Bulletin · 2018 · 17 citations · Full text

, , +16

Machine-Learning Guided Discovery of Bioactive Inhibitors of PD1-PDL1 Interaction

Sachin Patil, Elena Fattakhova, Jeremy Hofer et al. · Pharmaceuticals · 2022 · 17 citations · Full text

, , +17

Discovery of small-molecule PD-1/PD-L1 antagonists through combined virtual screening and experimental validation

Michelle DiFrancesco, Jeremy Hofer, Abhay G. Aradhya et al. · Computational Biology and Chemistry · 2022 · 17 citations

, , +16

Drug Repurposing for Covid-19: Discovery of Potential Small-Molecule Inhibitors of Spike Protein-ACE2 Receptor Interaction Through Virtual Screening and Consensus Scoring

Sachin Patil, Jeremy Hofer, Pedro J. Ballester et al. · ChemRxiv · 2020 · 13 citations · Full text

, , +17

1–5 of 5